Spectral Med Inc Cash Flow Conversion Efficiency

Latest as of September 2025: 0.039x

Spectral Med Inc cash flow conversion efficiency. Based on the latest financial reports, Spectral Med Inc (EDT) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-2.67 Million ≈ $-1.93 Million USD) by net assets (CA$-68.66 Million ≈ $-49.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Spectral Med Inc (1992–2024)

Cash flow conversion efficiency of Spectral Med Inc from 1992 to 2024. This chart illustrates how Spectral Med Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Spectral Med Inc (EDT) stock price for real-time trading data and today's change.

Spectral Med Inc Cash Flow Conversion Ratio Explained

Spectral Med Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Spectral Med Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Spectral Med Inc ranked by their cash flow conversion efficiency. Also see Spectral Med Inc stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Zwack Unicum Likoripari es Kereskedelmi Nyrt.
BUD:ZWACK
0.356x
PAMT CORP
NASDAQ:PAMT
-0.028x
Quang Viet Enterprise Co Ltd
TW:4438
-0.156x
AIRA Capital Public Company Limited
BK:AIRA
0.109x
D2L Inc
TO:DTOL
0.402x
Superior Uniform Group Inc
NASDAQ:SGC
0.049x
Smart Sand Inc
NASDAQ:SND
0.014x
TSS, Inc. Common Stock
NASDAQ:TSSI
0.095x

Annual Cash Flow Conversion Efficiency for Spectral Med Inc (1992–2024)

The table below shows the annual cash flow conversion efficiency of Spectral Med Inc from 1992 to 2024. Review cash generation quality of Spectral Med Inc to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CA$-27.55 Million
≈ $-19.93 Million
CA$-8.82 Million
≈ $-6.38 Million
0.320x -50.58%
2023-12-31 CA$-16.55 Million
≈ $-11.97 Million
CA$-10.72 Million
≈ $-7.76 Million
0.648x -83.29%
2022-12-31 CA$-2.55 Million
≈ $-1.85 Million
CA$-9.90 Million
≈ $-7.16 Million
3.876x +281.90%
2021-12-31 CA$4.08 Million
≈ $2.95 Million
CA$-8.70 Million
≈ $-6.29 Million
-2.131x -540.02%
2020-12-31 CA$-669.00K
≈ $-483.94K
CA$-324.00K
≈ $-234.38K
0.484x +139.98%
2019-12-31 CA$2.26 Million
≈ $1.63 Million
CA$-2.74 Million
≈ $-1.98 Million
-1.212x -224.12%
2018-12-31 CA$6.37 Million
≈ $4.61 Million
CA$-2.38 Million
≈ $-1.72 Million
-0.374x +70.28%
2017-12-31 CA$2.86 Million
≈ $2.07 Million
CA$-3.60 Million
≈ $-2.60 Million
-1.258x +34.17%
2016-12-31 CA$5.82 Million
≈ $4.21 Million
CA$-11.12 Million
≈ $-8.05 Million
-1.911x -13.63%
2015-12-31 CA$5.43 Million
≈ $3.93 Million
CA$-9.14 Million
≈ $-6.61 Million
-1.682x -48.20%
2014-12-31 CA$8.82 Million
≈ $6.38 Million
CA$-10.01 Million
≈ $-7.24 Million
-1.135x +29.68%
2013-12-31 CA$5.70 Million
≈ $4.12 Million
CA$-9.19 Million
≈ $-6.65 Million
-1.614x -120.87%
2012-12-31 CA$10.57 Million
≈ $7.65 Million
CA$-7.72 Million
≈ $-5.59 Million
-0.731x -120.57%
2011-12-31 CA$18.94 Million
≈ $13.70 Million
CA$-6.27 Million
≈ $-4.54 Million
-0.331x -16.50%
2010-12-31 CA$15.75 Million
≈ $11.39 Million
CA$-4.48 Million
≈ $-3.24 Million
-0.284x +64.97%
2009-12-31 CA$1.36 Million
≈ $987.42K
CA$-1.11 Million
≈ $-801.51K
-0.812x -528.74%
2008-12-31 CA$4.05 Million
≈ $2.93 Million
CA$-523.00K
≈ $-378.33K
-0.129x +4.00%
2007-12-31 CA$5.44 Million
≈ $3.94 Million
CA$-732.00K
≈ $-529.52K
-0.134x +26.00%
2006-12-31 CA$6.99 Million
≈ $5.06 Million
CA$-1.27 Million
≈ $-918.70K
-0.182x +96.81%
2005-12-31 CA$738.00K
≈ $533.86K
CA$-4.21 Million
≈ $-3.04 Million
-5.703x -500.54%
2004-12-31 CA$5.33 Million
≈ $3.85 Million
CA$-5.06 Million
≈ $-3.66 Million
-0.950x -71.08%
2003-12-31 CA$9.03 Million
≈ $6.53 Million
CA$-5.01 Million
≈ $-3.63 Million
-0.555x +48.99%
2002-12-31 CA$3.84 Million
≈ $2.78 Million
CA$-4.18 Million
≈ $-3.02 Million
-1.088x -1548.33%
2001-12-31 CA$8.19 Million
≈ $5.92 Million
CA$615.00K
≈ $444.88K
0.075x +111.47%
2000-12-31 CA$5.81 Million
≈ $4.20 Million
CA$-3.80 Million
≈ $-2.75 Million
-0.655x -35.38%
1999-12-31 CA$9.30 Million
≈ $6.73 Million
CA$-4.50 Million
≈ $-3.26 Million
-0.484x +13.98%
1998-12-31 CA$16.00 Million
≈ $11.57 Million
CA$-9.00 Million
≈ $-6.51 Million
-0.563x -47.94%
1997-12-31 CA$26.30 Million
≈ $19.03 Million
CA$-10.00 Million
≈ $-7.23 Million
-0.380x -36.39%
1996-12-31 CA$39.10 Million
≈ $28.28 Million
CA$-10.90 Million
≈ $-7.88 Million
-0.279x +36.15%
1995-12-31 CA$28.40 Million
≈ $20.54 Million
CA$-12.40 Million
≈ $-8.97 Million
-0.437x -128.79%
1994-12-31 CA$39.30 Million
≈ $28.43 Million
CA$-7.50 Million
≈ $-5.43 Million
-0.191x +5.18%
1993-12-31 CA$15.90 Million
≈ $11.50 Million
CA$-3.20 Million
≈ $-2.31 Million
-0.201x +66.75%
1992-12-31 CA$3.80 Million
≈ $2.75 Million
CA$-2.30 Million
≈ $-1.66 Million
-0.605x --

About Spectral Med Inc

TO:EDT Canada Diagnostics & Research
Market Cap
$198.70 Million
CA$274.68 Million CAD
Market Cap Rank
#16363 Global
#496 in Canada
Share Price
CA$0.95
Change (1 day)
-7.77%
52-Week Range
CA$0.88 - CA$1.50
All Time High
CA$1.89
About

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device … Read more